CLINICAL_TRIALS trial_result · 2011-11-11

Clinical Trial Update: A Study of MK2578 in Patients With Chronic Kidney Disease Who Are Not on Dialysis (2578-002) [Phase 2]

A Phase 2 clinical trial of MK2578 in patients with anemia due to chronic kidney disease was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Merck Sharp & Dohme LLC | Conditions: Anemia, Chronic Kidney Disease | Phase 2 | Status: TERMINATED | Results posted: 2011-11-11